Application 205329
- Type
- ANDA
- Sponsor
- XIROMED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVONORGESTREL | LEVONORGESTREL | TABLET;ORAL | 1.5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69953-516 | Morning After | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 69953-517 | Morning After | Levonorgestrel | Rapha Pharmaceuticals, Inc. | ANDA | Current |
| 70700-164 | Levonorgestrel | Levonorgestrel | Xiromed LLC | ANDA | Current |
| 70700-164 | Levonorgestrel | Levonorgestrel | Xiromed LLC | ANDA | Current |